Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 4/20 | 0.51 |
| ▸ | HTR2A | P28223 | 2/20 | 0.51 |
| ▸ | HTR2B | P41595 | 2/20 | 0.51 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.47 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 2/20 | 0.44 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL318344 | 1.00 | HTR2C (0.51) | HTR2CHTR2AHTR2BSLC9A1GID4 | |
| SCHEMBL317822 | 1.00 | HTR2C (0.51) | HTR2CHTR2AHTR2BSLC9A1GID4 | |
| SCHEMBL318343 | 1.00 | HTR2C (0.51) | HTR2CHTR2AHTR2BSLC9A1GID4 | |
| SCHEMBL9007090 | 0.97 | HTR2C (0.51) | HTR2CHTR2AHTR2BSLC9A1GID4 | |
| SCHEMBL318320 | 0.83 | ALDH1A1 (0.41) | HTR2C | |
| SCHEMBL318321 | 0.83 | ALDH1A1 (0.41) | HTR2C | |
| SCHEMBL318322 | 0.83 | ALDH1A1 (0.41) | HTR2C | |
| SCHEMBL4259949 | 0.81 | HTR2C (0.55) | HTR2CHTR2AHTR2BSLC9A1GID4 | |
| SCHEMBL10263051 | 0.81 | HTR2C (0.55) | HTR2CHTR2AHTR2BSLC9A1GID4 | |
| SCHEMBL757111 | 0.81 | HTR2C (0.55) | HTR2CHTR2AHTR2BSLC9A1GID4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8211904-B2 | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease | Merck, Sharp & Dohme Corp. (US) | 2012-07-03 | — | — | US | disclosed |
| EP-1910364-B1 | SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK SHARP & DOHME (US) | 2012-03-21 | — | — | EP | disclosed |
| WO-2007011833-A2 | SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO., INC. (US) | 2007-01-25 | — | — | WO | disclosed |